Pure Raw Supplies, LLC beneficially owns 12,000,000 Series B Preferred Shares of Nutra Pharma, representing 100% of the reported class. For investors, the disclosure identifies the holder and states that it has no present plans involving specified corporate actions, while the position was received as a gift without payment or borrowed funds.

Key Highlights

  • The holder says it has no current plans related to the corporate actions covered by Schedule 13D.
  • Pure Raw Supplies identifies pharmaceutical consulting as its principal business.
  • Pure Raw Supplies, LLC owns 12,000,000 Series B preferred shares of Nutra Pharma.

Nutra Pharma Corp (OTC: NPHC) has a reported holder with 12,000,000 Series B preferred shares, representing 100% of the reported class. Pure Raw Supplies, LLC holds the position for Investment purposes, according to the ownership disclosure.

12M Series B Preferred Shares Held

The transaction involved no payment or borrowed funds, and the holder said it was not part of a purchase transaction. Elizabeth Deitsch signed for Pure Raw Supplies as president on September 1. The Florida Limited Liability company lists its principal Business as pharmaceutical consulting. Pure Raw Supplies also stated that no person other than the holder has the right to receive dividends or direct proceeds from a sale of those shares.

No Current Plans for Listed Corporate Actions

The holder reported no transactions beyond those described in that section. The disclosure therefore identifies an investment-purpose position without a present proposal for those specified actions.